PT-141
PT-141 Research: Bremelanotide and Melanocortin Receptor Biology
PT-141, also known as bremelanotide, is a melanocortin receptor agonist peptide discussed through receptor pharmacology.
What PT-141 is
PT-141 is the research-code name commonly associated with bremelanotide. It is a synthetic peptide connected to melanocortin receptor pharmacology.
Melanocortin receptors are G-protein-coupled receptors. Different receptor subtypes participate in different signaling systems, which is why receptor selectivity is an important research topic in this compound family.
Research-use only: the material is supplied for laboratory research, not for human or veterinary administration.
Melanocortin receptor signaling
PT-141 is generally discussed as a melanocortin receptor agonist. An agonist binds a receptor and activates signaling rather than merely occupying the binding site.
Research models focus on ligand-receptor interaction, receptor subtype activity and downstream signaling cascades. PT-141 is often compared with other melanocortin peptides because small sequence and conformational changes can alter receptor behavior.
Difference from Melanotan 2
PT-141 and Melanotan 2 are related by the broader melanocortin peptide field, but they are not the same compound. PT-141 is usually discussed through bremelanotide and melanocortin receptor activation.
The shared receptor family creates overlap in terminology, while the compound identity, sequence design and research context remain distinct.
Research-use boundary
Unauthorized human-use risk context
This section is a safety boundary, not application guidance. The material is not supplied for human or veterinary administration, and the points below do not describe expected effects or acceptable use.
- Research-use material has not been supplied as a finished pharmaceutical product, so unauthorized human use can involve unknown identity, impurity, sterility, immune-response and contamination risks.
- Because this compound is discussed around melanocortin signaling, unauthorized human exposure could theoretically involve cardiovascular, pigment-pathway, neuroendocrine or receptor-mediated effects that are not characterized for this research material.
- If a non-sterile or improperly characterized material were introduced into the body, possible risks include infection, inflammatory reactions, fever-like responses, local tissue irritation and other serious adverse events.
